Timothy E. Betton

Array ( [id] => 8336133 [patent_doc_number] => 20120202840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases' [patent_app_type] => utility [patent_app_number] => 13/500162 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17332 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642658 [patent_doc_number] => 08367644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Methods and compounds useful to induce apoptosis in cancer cells' [patent_app_type] => utility [patent_app_number] => 12/900319 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8831 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12900319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953896 [patent_doc_number] => 20110034396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 12/807120 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27927 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034396.pdf [firstpage_image] =>[orig_patent_app_number] => 12807120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993553 [patent_doc_number] => 20110015206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHOD OF STABILIZING LIPID-RICH PLAQUE AND METHOD OF PREVENTING RUPTURE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/857671 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6066 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015206.pdf [firstpage_image] =>[orig_patent_app_number] => 12857671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402991 [patent_doc_number] => 20100305205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'COMPOSITION AND/OR METHOD FOR PREVENTING RECURRENCE OF STROKE' [patent_app_type] => utility [patent_app_number] => 12/852558 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8703 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305205.pdf [firstpage_image] =>[orig_patent_app_number] => 12852558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959550 [patent_doc_number] => 20110183937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Agent for Combating Ectoparasites' [patent_app_type] => utility [patent_app_number] => 12/841514 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1549 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183937.pdf [firstpage_image] =>[orig_patent_app_number] => 12841514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496453 [patent_doc_number] => 20100286104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'AGENT FOR INHIBITING VISCERAL FAT ACCUMULATION' [patent_app_type] => utility [patent_app_number] => 12/841076 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8777 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286104.pdf [firstpage_image] =>[orig_patent_app_number] => 12841076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524200 [patent_doc_number] => 08748464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Use of SIRT1 activators or inhibitors to modulate an immune response' [patent_app_type] => utility [patent_app_number] => 12/838247 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 42 [patent_no_of_words] => 24725 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12838247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402428 [patent_doc_number] => 20100305151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders' [patent_app_type] => utility [patent_app_number] => 12/830883 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11236 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305151.pdf [firstpage_image] =>[orig_patent_app_number] => 12830883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026014 [patent_doc_number] => 20110053913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Methods and Therapies for Alleviating Pain' [patent_app_type] => utility [patent_app_number] => 12/823934 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9911 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053913.pdf [firstpage_image] =>[orig_patent_app_number] => 12823934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071268 [patent_doc_number] => 20110046119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'THERAPEUTIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/813917 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4075 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046119.pdf [firstpage_image] =>[orig_patent_app_number] => 12813917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552321 [patent_doc_number] => 08759370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders' [patent_app_type] => utility [patent_app_number] => 12/797085 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 11219 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113160 [patent_doc_number] => 08569332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders' [patent_app_type] => utility [patent_app_number] => 12/795335 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 11226 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12795335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363736 [patent_doc_number] => 08252801 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-28 [patent_title] => 'Treatment of schizophrenia and related disorders' [patent_app_type] => utility [patent_app_number] => 12/793434 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16527 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12793434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003272 [patent_doc_number] => 20110118294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Intranasal Opioid Compositions' [patent_app_type] => utility [patent_app_number] => 12/755691 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10046 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118294.pdf [firstpage_image] =>[orig_patent_app_number] => 12755691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703986 [patent_doc_number] => 08829050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Compositions and methods for reducing body fat' [patent_app_type] => utility [patent_app_number] => 12/652968 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10948 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12652968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577148 [patent_doc_number] => 20100273829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal' [patent_app_type] => utility [patent_app_number] => 12/646146 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6370 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273829.pdf [firstpage_image] =>[orig_patent_app_number] => 12646146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446311 [patent_doc_number] => 20100144763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Pharmaceutical composition for inhibiting topoisomerase I and method for exploiting drug' [patent_app_type] => utility [patent_app_number] => 12/592965 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3722 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144763.pdf [firstpage_image] =>[orig_patent_app_number] => 12592965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200897 [patent_doc_number] => 08188034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation' [patent_app_type] => utility [patent_app_number] => 12/625401 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19659 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188034.pdf [firstpage_image] =>[orig_patent_app_number] => 12625401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536635 [patent_doc_number] => 20100204205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE AGENT BY USING THEM IN COMBINATION' [patent_app_type] => utility [patent_app_number] => 12/610419 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17637 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204205.pdf [firstpage_image] =>[orig_patent_app_number] => 12610419 [rel_patent_id] =>[rel_patent_doc_number] =>)